Results 11 to 20 of about 403,583 (300)

Conventional Synthetic Disease-Modifying Anti-rheumatic Drugs for Psoriatic Arthritis: Findings and Implications From a Patient Centered Longitudinal Study in Brazil

open access: yesFrontiers in Pharmacology, 2022
Background: Conventional synthetic disease-modifying antirheumatic drugs are the first-line treatment to inhibit the progression of psoriatic arthritis.
Ronaldo José Faria   +9 more
doaj   +1 more source

Antiparasitic Drugs in the United States—Two Roads to High Prices

open access: yesFrontiers in Sociology, 2020
High prescription drug prices contribute significantly to healthcare spending in the United States and compromise patients' access to quality medical care.
Arman A. Shahriar   +2 more
doaj   +1 more source

Decision-making on listing new medicines for public funding in New Zealand: the case of 'new' type 2 diabetes medications [PDF]

open access: yesJournal of Primary Health Care, 2022
IntroductionNew medicines for the management of type 2 diabetes became available internationally in 2005, yet only in 2018 did the first of these become available in New Zealand.
Caroline Stretton   +2 more
doaj  

Comparison of Five Protocols of Estrous Synchronization on Reproductive Performance of Hu Sheep

open access: yesFrontiers in Veterinary Science, 2022
The purpose of this study is to compare five protocols of estrous synchronization for Hu ewes to obtain the most effective and economical protocol, to apply the advantageous scheme in large-scale sheep farming.
Xiaojie Yu   +11 more
doaj   +1 more source

TRIPS to Where? A Narrative Review of the Empirical Literature on Intellectual Property Licensing Models to Promote Global Diffusion of Essential Medicines

open access: yesPharmaceutics, 2021
Governed through the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) since 1995, the current medical R&D system requires significant trade-offs between innovation and high monopoly prices for patented ...
Shiri Mermelstein, Hilde Stevens
doaj   +1 more source

Constructing a Real-Time Prescription Drug Monitoring System [PDF]

open access: yesHealthcare Informatics Research, 2016
ObjectivesThe objective of this investigation was to demonstrate the possibility of the construction of a real-time prescription drug monitoring system (PDMOS) using data from the nationwide Drug Utilization Review (DUR) system in Korea.MethodsThe DUR ...
Young-Taek Park   +2 more
doaj   +1 more source

The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan

open access: yesPLOS Global Public Health, 2022
Tuberculosis (TB) programs depend on a continuous supply of large amounts of high-quality TB drugs. When TB programs procure TB drugs from international suppliers, such as the Global Drug Facility, they can incur import costs for international transport,
Stefan Kohler   +3 more
doaj   +2 more sources

Direct healthcare costs and their relationships with age at start of drug use and current pattern of use: a cross-sectional study

open access: yesSão Paulo Medical Journal, 2021
BACKGROUND: It is well known that early start of drug use can lead users to psychosocial problems in adulthood, but its relationship with users’ direct healthcare costs has not been well established OBJECTIVES: To estimate the direct healthcare costs ...
Paula Becker, Denise Razzouk
doaj   +1 more source

Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales

open access: yesOrphanet Journal of Rare Diseases, 2023
Background The Orphan Regulation ((EC) No 141/2000) has successfully redirected private and public investment towards previously neglected areas through incentives, regulatory obligations and rewards.
Yankier Pijeira Perez   +2 more
doaj   +1 more source

Out-of-pocket expenditure for administration of benzathine penicillin G injections for secondary prophylaxis in patients with rheumatic heart disease: A registry-based data from a tertiary care center in Northern India

open access: yesIndian Heart Journal, 2021
Background: Costs can be a major barrier to medication adherence in low and middle-income countries and are an important target for policy-level interventions.
Balaji Arvind   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy